stoxline Quote Chart Rank Option Currency Glossary
  
IQVIA Holdings Inc. (IQV)
154.73  0.12 (0.08%)    06-20 16:00
Open: 155.725
High: 156.84
Volume: 2,589,928
  
Pre. Close: 154.61
Low: 153.82
Market Cap: 26,768(M)
Technical analysis
2025-06-20 4:41:30 PM
Short term     
Mid term     
Targets 6-month :  191.3 1-year :  223.44
Resists First :  163.78 Second :  191.3
Pivot price 152.08
Supports First :  145.78 Second :  134.64
MAs MA(5) :  155.91 MA(20) :  148.83
MA(100) :  168.04 MA(250) :  199.63
MACD MACD :  2.3 Signal :  1.4
%K %D K(14,3) :  65.9 D(3) :  70.7
RSI RSI(14): 55
52-week High :  252.88 Low :  134.64
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ IQV ] has closed below upper band by 40.2%. Bollinger Bands are 22.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 157.11 - 157.75 157.75 - 158.35
Low: 152.24 - 152.94 152.94 - 153.62
Close: 153.61 - 154.71 154.71 - 155.75
Company Description

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Headline News

Tue, 17 Jun 2025
Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - MarketScreener

Mon, 16 Jun 2025
IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN

Tue, 10 Jun 2025
IQVIA Holdings Inc (IQV) Trading 3.9% Higher on Jun 10 - GuruFocus

Mon, 02 Jun 2025
IQVIA Announces Offering of Senior Notes - Business Wire

Thu, 15 May 2025
Is IQVIA Holdings Inc. (IQV) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey

Wed, 07 May 2025
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 173 (M)
Shares Float 164 (M)
Held by Insiders 0.9 (%)
Held by Institutions 95.6 (%)
Shares Short 5,570 (K)
Shares Short P.Month 2,940 (K)
Stock Financials
EPS 7.32
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 34.33
Profit Margin 8.6 %
Operating Margin 13.7 %
Return on Assets (ttm) 5.3 %
Return on Equity (ttm) 21.6 %
Qtrly Rev. Growth 2.5 %
Gross Profit (p.s.) 31.09
Sales Per Share 89.59
EBITDA (p.s.) 16.93
Qtrly Earnings Growth -10.4 %
Operating Cash Flow 2,760 (M)
Levered Free Cash Flow 2,160 (M)
Stock Valuations
PE Ratio 21.1
PEG Ratio 0
Price to Book value 4.5
Price to Sales 1.72
Price to Cash Flow 9.69
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android